New insulin option tested for common diabetes
NCT ID NCT04980027
Summary
This study tested the safety and effectiveness of a long-acting insulin called Gla-300 in adults with type 2 diabetes. It involved 228 people whose blood sugar was not well controlled despite taking diabetes pills. The goal was to see if adding this once-daily insulin injection was safe and helped improve blood sugar control over 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site Number 3560003
Jaipur, 302017, India
-
Investigational site Number 3560013
Nashik, 422002, India
Conditions
Explore the condition pages connected to this study.